CGAS and Chagas cardiomyopathy: The pharmacological inhibition of cGAS using PF-06928215 significantly reduced the production of these pro-inflammatory cytokines, implicating the cGAS/STING pathway in the inflammatory pathogenesis of Chagas cardiomyopathy [38].